On December 27, 2022, Innovation1 Biotech Inc. closed the transaction. The company received final tranche of $150,000 from 3 investors. The company will issue securities pursuant to exemption provided under Regulation D. The minimum investment accepted from outsiders is $100,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% | -.--% | -99.07% |
17/01 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+205.14% | 7.06B | |
+2.10% | 982M | |
-3.96% | 954M | |
+41.91% | 872M | |
+22.24% | 800M | |
+1.34% | 664M | |
+7.72% | 659M | |
-.--% | 600M | |
+3.61% | 503M |
- Stock Market
- Equities
- IVBT Stock
- News Innovation1 Biotech Inc.
- Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC